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a b s t r a c t
Melorheostosis is a rare disease (0.9/million habitants), characterized by linear hyperostosis 
along the cortex bone. It can affect any bone, being more frequent in long bones. The lesions 
tend to be segmental and unilateral. The etiology remains unknown although several theories 
proposed over the past year (vascular, inflammatory processes, embryonic defects or genetic). 
Show no significant difference between sexes or heredity. Clinical manifestations are mainly 
pain, deformity and joint stiffness. The diagnosis is obtained by combining the clinical findings 
with imaging studies (mainly radiography with typical image in “candle wax”). There is no 
definitive or specific treatment, being always palliative. We describe a case of a patient of 
twenty-four years, followed in Orthopedic consultation since age eight, with a deformity of the 
right side of the body. X-rays showed hyperostosis of the bones of the limbs in the right side of 
the body (image in “candle wax”). The patient is in physical therapy program and has a positive 
response to analgesia with ibuprofen.
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora 
Ltda. 
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Introduction
Melorheostosis is characterized by linear hyperostosis along 
the bone cortex. It is more common in the long bones, although 
it can affect any bone of any segment of the human body and 
tends to be segmental and unilateral.1 
The incidence is 0.9 cases per million inhabitants,2 and 
there are approximately 300 cases described in the literature. 
Melorheostosis affects men and women in equal proportions, 
and cases have been described in children and adults.
The etiology is unknown, despite several theories proposed 
over the past several years (vascular alterations, inflammatory 
processes and embryonic or genetic defects).3 
Clinically, the main symptom is local pain aggravated by 
mobilization of the affected segment. Melorheostosis can also 
be characterized by recurrent joint effusions, bone deformity 
and joint stiffness.4 
The diagnosis, in most cases, can be attained by 
radiographic assessment (“dripping candle wax” sign)1 and 
can be aided by analytical (normal serum calcium, phosphorus 
and alkaline phosphatase) and anatomopathological tests 
(the histological findings are nonspecific and often show a 
mixture of mature and immature bone in a dense formation 
with increased trabecular bone)1 or by scintigraphy (higher 
uptake).
There is no specific treatment for melorheostosis; rather, 
treatment is symptomatic and involves the use of analgesic 
or anti-inflammatory drugs.
Case Report
We report the clinical case of a 24-year-old patient without any 
known toxic habits who was also not addicted to any drugs. He 
had been followed as an outpatient at the Orthopedics Service 
since the age of 8 due to insidious onset pain in the limbs of 
the right hemibody (more marked in the lower limb). During 
the follow-up, he showed a gradual increase in dysmorphia in 
these limbs, which manifested at that time as a 4-cm increase 
in the upper limb (compared with the contralateral upper 
limb) and a 5-cm increase in the lower limb (compared with 
the contralateral lower limb). 
Clinically, the patient had diffuse swelling in the 
affected limbs, with increased local temperature and 
hyperpigmentation. All the joints of the affected segments 
showed decreased range of motion compared with the healthy 
limbs. 
Radiographs of the affected segments showed bone 
hyperostosis of the limbs in the right hemisphere (except 
the radius, the 1st and 5th rays of the hand and the 5th ray of 
the foot), with the typical “dripping candle wax” sign (Figs. 1, 
2, 3, 4 and 5). 
In the laboratory assessment, no alterations were found 
in any of the parameters, notably serum calcium, alkaline 
phosphatase, C-reactive protein or erythrocyte sedimentation 
rate. 
The histopathology report of the femur biopsy disclosed: 
“Large areas of bone tissue with cortical appearance and 
haversian systems of different calibers combined with areas 
of spongy bone. The joint injury suggests sclerosing bone 
dysplasia.”
The patient is currently in a physical therapy program, 
receives analgesia with ibuprofen (400 mg) and has shown a 
good response to treatment. He is being clinically followed.
Fig. 1 - Upper limb X-ray.
Fig. 2 - Forearm X-ray.
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Discussion
Melorheostosis is a rare disease first described in 1922 by 
Leri and Joanny.5 It can occur at any age and affects both sex 
equally.6 
The etiology is unknown, although several theories have 
been proposed, such as a mesenchymal cell differentiation 
defect (genetic mutation in LEMD3), vascular disorders or 
inflammatory processes.3 None of these theories have been 
completely proven. 
The symptoms vary considerably from asymptomatic to 
severe pain with associated deformity. The onset of complaints 
is usually insidious, with pain, joint stiffness, skin alterations 
and bone deformity.4 Our patient began to experience insidious 
pain at 8 years old, with progressive deformity that has 
continued to the present.  
Regarding the distribution of lesions, they can affect one 
limb (monomelic, which is the most common) or both upper 
and lower limbs (hemimelic). The condition can be either 
monostotic or polyostotic if it affects one or many bones, 
respectively.7 The distribution in our patient was hemimelic 
and polyostotic, which is rare. The condition mainly affects the 
long bones, but rarely the axial skeleton,1 as observed in the 
aforementioned patient. 
The diagnosis is based on radiographic findings (typical 
“dripping candle wax” sign) characterized by areas of 
hyperostosis with increased cortical bone thickness and linear 
density areas in the cortex that can extend into cancellous 
bone.1 Our patient had clear radiographic findings that were 
Fig. 3 - Hand X-ray.
Fig. 4 - Lower limb X-ray.
Fig. 5 - Foot X-ray.
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typical of melorheostosis. The laboratory assessment revealed 
no alterations, as often occurs in this type of pathology. 
The histological findings are nonspecific and often show a 
mixture of mature and immature bone in a dense formation 
with increased trabecular bone. Osteoclastic activity is unusual, 
although marginal osteoblast formation is common.1 These 
characteristics are comparable to those of our case. 
Treatment is symptomatic in most cases. Surgical treatment 
is reserved for contractures and deformities.1 Our patient has 
been treated with a nonsteroidal anti-inflammatory drug 
(ibuprofen 400 mg) with good symptomatic response.
Melorheostosis is an extremely rare disease characterized 
by linear hyperostosis along the bone cortex. Clinically, it 
progresses with episodes of local pain and deformity. Diagnosis 
is achieved by a combination of clinical assessment and 
imaging tests. 
There is no specific treatment, and therapy is essentially 
palliative. 
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